Oral Viscous Budesonide clinical trial - RECRUITING

Parents have few medical options when it comes to treatment for eosinophilic esophagitis (EoE) in children and adolescents.  In fact, there are no FDA-approved medicines currently available. 

OVB is currently being studied in a dose-ranging Phase 2b clinical trial in children and adolescents with EoE. The double-blind, randomized, placebo-controlled 12-week study in up to 80 patients with confirmed EoE aged two to 18 is designed to evaluate three different doses of OVB. Patients will be evaluated by performing biopsies of the esophagus obtained before and after OVB administration as well as their symptomatic response to therapy. The trial is being conducted at multiple U.S. clinical centers that specialize in the treatment of patients with gastrointestinal diseases.

Please click here for more information or visit www.thepeerstudy.net.